drugset / Trial / NCT02793232
Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.
RandomizedCrossoverDouble-blindBasic science
Summary
This study will test the safety, tolerability and blood concentrations of single and multiple oral doses of PF-06751979 in health subjects and healthy elderly subjects. PF-06751979 is being developed for the treatment of Alzheimer's disease.
Timeline
- Start
- 2016-06-13
- Primary completion
- 2017-01-05
- Completion
- 2017-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06751979 | Unknown | 100 mg | Oral |
| Subject | PF-06751979 | Unknown | 200 mg | Oral |
| Subject | PF-06751979 | Unknown | 340 mg | Oral |
| Subject | PF-06751979 | Unknown | 400 mg | Oral |
| Subject | PF-06751979 | Unknown | 700 mg | Oral |
Indications
No indication recorded.